Bacterial Infections
RSSArticles
-
Resistance Erodes Standard Treatment for Pneumonia
These data suggest community-acquired pneumonia CAP therapy may no longer be relevant for many patients with CAP, and the required use of the current CAP bundle with limited antibacterial therapy choices should be re-assessed.
-
College Students Need Better STI, Sexual Violence Education
Nearly two-thirds of college students reported having experienced sexual and/or physical violence at some time in their lives, according to the results of a new study. -
Better Education on Sexually Transmitted Infections Is Needed
A small study of women who responded to a study recruitment flier that offered a free, rapid HIV test revealed the participants knew very little about sexually transmitted infections. -
Pandemic Unlikely to Have Stopped Trend of Rising STDs, Researchers Suggest
The 2019 STD Surveillance Report noted annual cases of STDs in the United States reached an all-time high in 2019 for the sixth consecutive year. In 2019, there were 2.5 million reported cases of chlamydia, gonorrhea, and syphilis, and a nearly 30% increase in reportable STDs between 2015 and 2019. Data from 2020 showed a similar trend of high STD cases in the first 11 weeks of 2020, but reported cases were much lower than 2019 cases for a week in April 2020. -
Updated 2021 Sexually Transmitted Infections Treatment Guidelines
The CDC updated their sexually transmitted infections treatment guidelines with new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.
-
Proton-Pump Inhibitors and Community-Associated Clostridioides difficile Infection
A nationwide cohort study of adults in Denmark found that proton-pump inhibitor (PPI) use was associated with a moderately increased risk of community-associated Clostridioides difficile infection, and the risk remained elevated up to one year after PPI treatment had ended.
-
Clostridioides difficile Infection: Guideline Update
Fidaxomicin is preferred over vancomycin for initial and recurrent cases. Bezlotoxumab is recommended in many cases of recurrent infection and initial infection in patients at high risk of recurrence.
-
Logistical, Economic Barriers Hinder Updated Treatment Options for Common Infection
The treatment options are evolving, but stubborn road blocks remain.
-
Record Number of Reported STD Cases for Sixth Straight Year
U.S. cases of chlamydia, gonorrhea, and syphilis rose almost 30% between 2015 and 2019.
-
Streamlined Lyme Disease Guidelines for Frontline Providers
With the peak period for Lyme disease approaching, new guidelines help clinicians understand when to consider the ailment in patients who present to the ED, how to properly diagnosis a case, and how to treat.